Literature DB >> 26192268

Increased Frequency of CD49b/LAG-3(+) Type 1 Regulatory T Cells in HIV-Infected Individuals.

Kristina Koch1, Nora Koch1, Ute Sandaradura de Silva1, Norma Jung1, Julian Schulze zur Wiesch2, Gerd Fätkenheuer1,3, Pia Hartmann1,3, Fabio Romerio4, Clara Lehmann1,3.   

Abstract

In HIV-1 infection elevated serum levels of interferon-α (IFN-α) and interleukin-10 (IL-10) are associated with immune hyperactivation and disease progression. Recently, coexpression of CD49b and LAG-3 was shown to identify Type 1 regulatory T (Tr1) cells, which secrete large amounts of the immunosuppressive cytokine IL-10. We analyzed the frequency of CD49b/LAG-3(+) Tr1 cells in the peripheral blood of HIV-infected individuals at different stages of the disease. We found increased levels of CD49b/LAG-3(+) Tr1 cells as well as IL-10 in HIV patients. With disease progression, Tr1 cells negatively correlate with frequency of plasmacytoid dendritic cells (pDCs), the main producers of IFN-α. However, elevated IL-10 levels could not be ascribed to the CD49b/LAG-3(+)Tr1 cell population. Moreover, we showed in vitro that IFN-α leads to an upregulation of IL-10 as well as CD49b/LAG-3(+) Tr1 cell counts in healthy controls, recapitulating effects observed in vivo during HIV infection. Our results suggest that overexpression of IFN-α during HIV infection drives the generation of CD49b/LAG-3(+) Tr1 cells and the immunosuppressive cytokine IL-10. Furthermore, it remains unclear whether elevated IL-10 levels are beneficial or detrimental in regard to disease progression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26192268     DOI: 10.1089/AID.2014.0356

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Regulatory T cells in retroviral infections.

Authors:  Kim J Hasenkrug; Claire A Chougnet; Ulf Dittmer
Journal:  PLoS Pathog       Date:  2018-02-15       Impact factor: 6.823

Review 3.  The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?

Authors:  Hui Chen; Maha Moussa; Marta Catalfamo
Journal:  Front Immunol       Date:  2020-07-02       Impact factor: 7.561

4.  Molecular and functional heterogeneity of IL-10-producing CD4+ T cells.

Authors:  Leonie Brockmann; Shiwa Soukou; Babett Steglich; Paulo Czarnewski; Lilan Zhao; Sandra Wende; Tanja Bedke; Can Ergen; Carolin Manthey; Theodora Agalioti; Maria Geffken; Oliver Seiz; Sara M Parigi; Chiara Sorini; Jens Geginat; Keishi Fujio; Thomas Jacobs; Thomas Roesch; Jacob R Izbicki; Ansgar W Lohse; Richard A Flavell; Christian Krebs; Jan-Ake Gustafsson; Per Antonson; Maria Grazia Roncarolo; Eduardo J Villablanca; Nicola Gagliani; Samuel Huber
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

Review 5.  Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy.

Authors:  Yihang Qi; Li Chen; Qiang Liu; Xiangyi Kong; Yi Fang; Jing Wang
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 6.  The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application.

Authors:  Ece Canan Sayitoglu; Robert Arthur Freeborn; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.